Mark Schoenberg

2019

In 2019, Mark Schoenberg earned a total compensation of $800.9K as Chief Medical Officer at UroGen Pharma Ltd., a 167% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$270,000
Option Awards$218,054
Salary$205,000
Stock Awards$106,250
Other$1,604
Total$800,908

Schoenberg received $270K in non-equity incentive plan, accounting for 34% of the total pay in 2019.

Schoenberg also received $218.1K in option awards, $205K in salary, $106.3K in stock awards and $1.6K in other compensation.

Rankings

In 2019, Mark Schoenberg's compensation ranked 10,213th out of 13,971 executives tracked by ExecPay. In other words, Schoenberg earned more than 26.9% of executives.

ClassificationRankingPercentile
All
10,213
out of 13,971
27th
Division
Manufacturing
4,132
out of 5,701
28th
Major group
Chemicals And Allied Products
1,576
out of 2,200
28th
Industry group
Drugs
1,350
out of 1,886
28th
Industry
Pharmaceutical Preparations
1,006
out of 1,398
28th

Pay ratio

Mark Schoenberg's Pay$800,908
Median Employee's Pay$223,867
Pay Ratio

4

to 1

In 2019, the annual total compensation of Mark Schoenberg was $800,908.

The annual total compensation of the median employee at UroGen Pharma Ltd. was $223,867.

The ratio of Mark Schoenberg's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on April 29, 2020.

Schoenberg's colleagues

We found four more compensation records of executives who worked with Mark Schoenberg at UroGen Pharma Ltd. in 2019.

2019

Elizabeth Barrett

UroGen Pharma Ltd.

Chief Executive Officer

2019

Peter Pfreundschuh

UroGen Pharma Ltd.

Chief Financial Officer

2019

Stephen Mullennix

UroGen Pharma Ltd.

Chief Operating Officer

2019

Ron Bentsur

UroGen Pharma Ltd.

Chief Executive Officer

News

You may also like